Search

Your search keyword '"Marjolein van Egmond"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Marjolein van Egmond" Remove constraint Author: "Marjolein van Egmond" Search Limiters Full Text Remove constraint Search Limiters: Full Text
94 results on '"Marjolein van Egmond"'

Search Results

1. Intrathecal IgG and IgM synthesis correlates with neurodegeneration markers and corresponds to meningeal B cell presence in MS

2. Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity

3. Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiota

4. Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease

5. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop

6. Clickable Vitamins as a New Tool to Track Vitamin A and Retinoic Acid in Immune Cells

7. IgA Immune Complexes Induce Osteoclast-Mediated Bone Resorption

8. A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy

9. Oral Antibiotic Prophylaxis Reduces Surgical Site Infection and Anastomotic Leakage in Patients Undergoing Colorectal Cancer Surgery

10. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities

11. Surgery for Colorectal Cancer: A Trigger for Liver Metastases Development? New Insights into the Underlying Mechanisms

12. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils

13. Spillage of bacterial products during colon surgery increases the risk of liver metastases development in a rat colon carcinoma model.

14. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.

15. The Role of Macrophages in Tumor Development

16. Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells

17. The importance of human FcgammaRI in mediating protection to malaria.

18. Supplemental Movie 2 from Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer

19. Supplemental Movie 1 from Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer

20. Detection of Circulating Tumor Cells Using the Attune NxT

21. The present and future of immunocytokines for cancer treatment

22. Mechanisms of colorectal liver metastasis development

23. Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching

24. Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer

25. Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils

26. IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity

27. Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells

28. Neutrophils as immune effector cells in antibody therapy in cancer

29. Therapeutic exploitation of neutrophils to fight cancer

30. NK cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models

31. The role of retinoic acid in the production of immunoglobulin A

32. Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity

33. CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors

34. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)

35. Mesangial deposition can strongly involve innate-like iga molecules lacking affinity maturation

36. Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers

37. Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice

38. Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells

39. Granulocytes as modulators of dendritic cell function

40. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

41. IgA Enhances NETosis and Release of Neutrophil Extracellular Traps by Polymorphonuclear Cells via Fc alpha Receptor I

42. Immunoglobulin A: magic bullet or Trojan horse?

43. Blocking alpha 1-integrin reverts the adhesive phenotype of adult fibroblasts towards a foetal-like migratory phenotype

44. CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction

45. Immunoglobulin A: A next generation of therapeutic antibodies?

46. Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining

47. Monoclonal antibody-mediated killing of tumour cells by neutrophils

48. c-Jun activating binding protein 1 binds to the IgA receptor and modulates protein levels of FcαRI and FcRγ-chain

49. Erratum

50. FcR γ-Chain Dependent Signaling in Immature Neutrophils Is Mediated by FcαRI, but Not by FcγRI

Catalog

Books, media, physical & digital resources